Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins

Virology

Volumn 477, Issue , 2015, Pages 18-31

  Yang, Hua ^a   Carney, Paul J ^a   Chang, Jessie C ^a   Guo, Zhu ^a   Villanueva, Julie M ^a   Stevens, James ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Glycan microarray; H3N2; Hemagglutinin; Influenza virus; Receptor specificity

Indexed keywords

GLYCAN; INFLUENZA VIRUS HEMAGGLUTININ; MUTANT PROTEIN; PROTEIN BINDING; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; INFLUENZA VIRUS A H3N2; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR BINDING; VIRUS TRANSMISSION; GENETICS; HUMAN; INFLUENZA; INFLUENZA A VIRUS (H3N2); ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; VIROLOGY;

ORTHOMYXOVIRIDAE;

EVOLUTION, MOLECULAR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MUTANT PROTEINS; PROTEIN BINDING; RECEPTORS, VIRUS;

EID: 84921482027     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.12.024     Document Type: Article

References (94)

1. Abe Y., Takashita E., Sugawara K., Matsuzaki Y., Muraki Y., Hongo S. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol. 2004, 78:9605-9611.
2. Adams P.D., Afonine P.V., Bunkoczi G., Chen V.B., Davis I.W., Echols N., Headd J.J., Hung L.W., Kapral G.J., Grosse-Kunstleve R.W., McCoy A.J., Moriarty N.W., Oeffner R., Read R.J., Richardson D.C., Richardson J.S., Terwilliger T.C., Zwart P.H. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr., D: Biol. Crystallogr. 2010, 66:213-221.
3. Asaoka N., Tanaka Y., Sakai T., Fujii Y., Ohuchi R., Ohuchi M. Low growth ability of recent influenza clinical isolates in MDCK cells is due to their low receptor binding affinities. Microbes Infect./Inst. Pasteur 2006, 8:511-519.
4. Aytay S., Schulze I.T. Single amino acid substitutions in the hemagglutinin can alter the host range and receptor binding properties of H1 strains of influenza A virus. J. Virol. 1991, 65:3022-3028.
5. Baum L.G., Paulson J.C. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem. Suppl. 1990, 40:35-38.
6. Bean W.J., Schell M., Katz J., Kawaoka Y., Naeve C., Gorman O., Webster R.G. Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J. Virol. 1992, 66:1129-1138.
7. Blixt O., Head S., Mondala T., Scanlan C., Huflejt M.E., Alvarez R., Bryan M.C., Fazio F., Calarese D., Stevens J., Razi N., Stevens D.J., Skehel J.J., van Die I., Burton D.R., Wilson I.A., Cummings R., Bovin N., Wong C.H., Paulson J.C. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17033-17038.
8. Bush R.M., Bender C.A., Subbarao K., Cox N.J., Fitch W.M. Predicting the evolution of human influenza A. Science 1999, 286:1921-1925.
9. Bush R.M., Fitch W.M., Bender C.A., Cox N.J. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol. Biol. Evol. 1999, 16:1457-1465.
10. Byrd-Leotis L., Liu R., Bradley K.C., Lasanajak Y., Cummings S.F., Song X., Heimburg-Molinaro J., Galloway S.E., Culhane M.R., Smith D.F., Steinhauer D.A., Cummings R.D. Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E2241-E2250.
11. Chayen N.E. Optimization techniques for automation and high throughput. Methods Mol. Biol. 2007, 363:175-190.
12. Childs R.A., Palma A.S., Wharton S., Matrosovich T., Liu Y., Chai W., Campanero-Rhodes M.A., Zhang Y., Eickmann M., Kiso M., Hay A., Matrosovich M., Feizi T. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 2009, 27:797-799.
13. Connor R.J., Kawaoka Y., Webster R.G., Paulson J.C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994, 205:17-23.
14. Couceiro J.N., Paulson J.C., Baum L.G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 1993, 29:155-165.
15. Daniels P.S., Jeffries S., Yates P., Schild G.C., Rogers G.N., Paulson J.C., Wharton S.A., Douglas A.R., Skehel J.J., Wiley D.C. The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J. 1987, 6:1459-1465.
16. Daniels R.S., Douglas A.R., Skehel J.J., Wiley D.C. Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J. Gen. Virol. 1983, 64(Pt 8):1657-1662.
17. Das S.R., Hensley S.E., David A., Schmidt L., Gibbs J.S., Puigbo P., Ince W.L., Bennink J.R., Yewdell J.W. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E1417-E1422.
18. Davis I.W., Leaver-Fay A., Chen V.B., Block J.N., Kapral G.J., Wang X., Murray L.W., Arendall W.B., Snoeyink J., Richardson J.S., Richardson D.C. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007, 35:W375-W383.
19. Delano, W.L., 2002. The Pymol Molecular Graphics System. http://www.pymol.org.
20. Emsley P., Lohkamp B., Scott W.G., Cowtan K. Features and development of Coot. Acta Crystallogr., D: Biol. Crystallogr. 2010, 66:486-501.
21. Fouchier R.A., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwaan G.F., Olsen B., Osterhaus A.D. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 2005, 79:2814-2822.
22. Frank S., Kammerer R.A., Mechling D., Schulthess T., Landwehr R., Bann J., Gou Y., Lustig A., Bächinger H.P., Engel J. Stabilization of short collagen-like triple helices by protein engineering. J. Mol. Biol. 2001, 308:1081-1089.
23. Gao R., Cao B., Hu Y., Feng Z., Wang D., Hu W., Chen J., Jie Z., Qiu H., Xu K., Xu X., Lu H., Zhu W., Gao Z., Xiang N., Shen Y., He Z., Gu Y., Zhang Z., Yang Y., Zhao X., Zhou L., Li X., Zou S., Zhang Y., Yang L., Guo J., Dong J., Li Q., Dong L., Zhu Y., Bai T., Wang S., Hao P., Yang W., Han J., Yu H., Li D., Gao G.F., Wu G., Wang Y., Yuan Z., Shu Y. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 2013, 368:1888-1897.
24. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
25. Glaser L., Stevens J., Zamarin D., Wilson I.A., Garcia-Sastre A., Tumpey T.M., Basler C.F., Taubenberger J.K., Palese P. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol. 2005, 79:11533-11536.
26. Grassauer A., Egorov A.Y., Ferko B., Romanova I., Katinger H., Muster T. A host restriction-based selection system for influenza haemagglutinin transfectant viruses. J. Gen. Virol. 1998, 79(Pt 6):1405-1409.
27. Gulati S., Smith D.F., Cummings R.D., Couch R.B., Griesemer S.B., George K., Webster R.G., Air G.M. Human H3N2 influenza viruses isolated from 1968 to 2012 show varying preference for receptor substructures with no apparent consequences for disease or spread. PLoS One 2013, 8:e66325.
28. Hebert D.N., Zhang J.X., Chen W., Foellmer B., Helenius A. The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J. Cell Biol. 1997, 139:613-623.
29. Hensley S.E., Das S.R., Bailey A.L., Schmidt L.M., Hickman H.D., Jayaraman A., Viswanathan K., Raman R., Sasisekharan R., Bennink J.R., Yewdell J.W. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009, 326:734-736.
30. Herfst S., Schrauwen E.J., Linster M., Chutinimitkul S., de Wit E., Munster V.J., Sorrell E.M., Bestebroer T.M., Burke D.F., Smith D.J., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012, 336:1534-1541.
31. Imai M., Kawaoka Y. The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr. Opin. Virol. 2012, 2:160-167.
32. Imai M., Watanabe T., Hatta M., Das S.C., Ozawa M., Shinya K., Zhong G., Hanson A., Katsura H., Watanabe S., Li C., Kawakami E., Yamada S., Kiso M., Suzuki Y., Maher E.A., Neumann G., Kawaoka Y. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012, 486:420-428.
33. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227:493-499.
34. Kaverin N.V., Rudneva I.A., Ilyushina N.A., Varich N.L., Lipatov A.S., Smirnov Y.A., Govorkova E.A., Gitelman A.K., Lvov D.K., Webster R.G. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol. 2002, 83:2497-2505.
35. Kobayashi Y., Suzuki Y. Evidence for N- glycan shielding of antigenic sites during evolution of human influenza a virus hemagglutinin. J. Virol. 2012, 86:3446-3451.
36. Kumari K., Gulati S., Smith D.F., Gulati U., Cummings R.D., Air G.M. Receptor binding specificity of recent human H3N2 influenza viruses. Virol. J. 2007, 4:42.
37. Land A., Braakman I. Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum. Biochimie 2001, 83:783-790.
38. Lin Y.P., Xiong X., Wharton S.A., Martin S.R., Coombs P.J., Vachieri S.G., Christodoulou E., Walker P.A., Liu J., Skehel J.J., Gamblin S.J., Hay A.J., Daniels R.S., McCauley J.W. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc. Natl. Acad. Sci. U.S.A 2012.
39. Lu B., Zhou H., Chan W., Kemble G., Jin H. Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs. Vaccine 2006, 24:6691-6693.
40. Matrosovich M., Tuzikov A., Bovin N., Gambaryan A., Klimov A., Castrucci M.R., Donatelli I., Kawaoka Y. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 2000, 74:8502-8512.
41. Matrosovich M., Zhou N., Kawaoka Y., Webster R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 1999, 73:1146-1155.
42. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4620-4624.
43. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J. Appl. Crystallogr. 2007, 40:658-674.
44. Medeiros R., Escriou N., Naffakh N., Manuguerra J.-C., van der Werf S. Hemagglutinin residues of recent human A(H3N2) viruses that affect agglutination of chicken erythrocytes. Int. Congr. Ser. 2001, 1219:369-374.
45. Meunier J.C., Fournillier A., Choukhi A., Cahour A., Cocquerel L., Dubuisson J., Wychowski C. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J. Gen. Virol. 1999, 80(Pt 4):887-896.
46. Nicholls J.M., Chan M.C., Chan W.Y., Wong H.K., Cheung C.Y., Kwong D.L., Wong M.P., Chui W.H., Poon L.L., Tsao S.W., Guan Y., Peiris J.S. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 2007, 13:147-149.
47. Nobusawa E., Ishihara H., Morishita T., Sato K., Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 2000, 278:587-596.
48. Nycholat C.M., McBride R., Ekiert D.C., Xu R., Rangarajan J., Peng W., Razi N., Gilbert M., Wakarchuk W., Wilson I.A., Paulson J.C. Recognition of sialylated poly-N-acetyllactosamine chains on N- and O-linked glycans by human and avian influenza A virus hemagglutinins. Angew. Chem. Int. Ed. 2012, 51:4860-4863.
49. Oh D.Y., Barr I.G., Mosse J.A., Laurie K.L. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J. Clin. Microbiol. 2008, 46:2189-2194.
50. Otwinowski Z., Minor W. Scalepack Manual 1997.
51. Owen R.E., Yamada E., Thompson C.I., Phillipson L.J., Thompson C., Taylor E., Zambon M., Osborn H.M., Barclay W.S., Borrow P. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J. Virol. 2007, 81:11170-11178.
52. Pereira M.S., Schild G.C. An antigenic variant of the Hong Kong-68 influenza A 2 virus. J. Hyg. (Lond.) 1971, 69:99-103.
53. Popova L., Smith K., West A.H., Wilson P.C., James J.A., Thompson L.F., Air G.M. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses. PLoS One 2012, 7:e41895.
54. Reid A.H., Taubenberger J.K. The origin of the 1918 pandemic influenza virus: a continuing enigma. J. Gen. Virol. 2003, 84:2285-2292.
55. Rogers G.N., D'Souza B.L. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 1989, 173:317-322.
56. Rogers G.N., Daniels R.S., Skehel J.J., Wiley D.C., Wang X.F., Higa H.H., Paulson J.C. Host-mediated selection of influenza virus receptor variants. Sialic acid-α2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-α2,3Gal-specific wild type in ovo. J. Biol. Chem. 1985, 260:7362-7367.
57. Rogers G.N., Paulson J.C., Daniels R.S., Skehel J.J., Wilson I.A., Wiley D.C. Single amino acid substitutions in influenza hemagglutinin change receptor binding specificity. Nature 1983, 304:76-78.
58. Scholtissek C., Rohde W., Von Hoyningen V., Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 1978, 87:13-20.
59. Seidel W., Kunkel F., Geisler B., Garten W., Herrmann B., Dohner L., Klenk H.D. Intraepidemic variants of influenza virus H3 hemagglutinin differing in the number of carbohydrate side chains. Arch. Virol. 1991, 120:289-296.
60. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006, 440:435-436.
61. Skehel J.J., Stevens D.J., Daniels R.S., Douglas A.R., Knossow M., Wilson I.A., Wiley D.C. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:1779-1783.
62. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Ann. Rev. Biochem. 2000, 69:531-569.
63. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376.
64. Stevens J., Blixt O., Chen L.M., Donis R.O., Paulson J.C., Wilson I.A. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J. Mol. Biol. 2008, 381:1382-1394.
65. Stevens J., Blixt O., Glaser L., Taubenberger J.K., Palese P., Paulson J.C., Wilson I.A. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 2006, 355:1143-1155.
66. Stevens J., Blixt O., Paulson J.C., Wilson I.A. Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat. Rev. Microbiol. 2006, 4:857-864.
67. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006, 312:404-410.
68. Stevens J., Chen L.M., Carney P.J., Garten R., Foust A., Le J., Pokorny B.A., Manojkumar R., Silverman J., Devis R., Rhea K., Xu X., Bucher D.J., Paulson J., Cox N.J., Klimov A., Donis R.O. Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J. Virol 2010.
69. Stevens J., Corper A.L., Basler C.F., Taubenberger J.K., Palese P., Wilson I.A. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 2004, 303:1866-1870.
70. Stray S.J., Pittman L.B. Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin. Virol. J. 2012, 9:91.
71. Thompson M.G., Shay D.K., Zhou H., Bridges C.B., Cheng P.Y., Burns E., Bresee J.S., Cox N.J. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb. Mortal. Wkly. Rep. 2010, 59:1057-1062.
72. Tong S., Li Y., Rivailler P., Conrardy C., Castillo D.A., Chen L.M., Recuenco S., Ellison J.A., Davis C.T., York I.A., Turmelle A.S., Moran D., Rogers S., Shi M., Tao Y., Weil M.R., Tang K., Rowe L.A., Sammons S., Xu X., Frace M., Lindblade K.A., Cox N.J., Anderson L.J., Rupprecht C.E., Donis R.O. A distinct lineage of influenza A virus from bats. Proc. Natl. Acad. Sci. U.S.A 2012.
73. Tong S., Zhu X., Li Y., Shi M., Zhang J., Bourgeois M., Yang H., Chen X., Recuenco S., Gomez J., Chen L.M., Johnson A., Tao Y., Dreyfus C., Yu W., McBride R., Carney P.J., Gilbert A.T., Chang J., Guo Z., Davis C.T., Paulson J.C., Stevens J., Rupprecht C.E., Holmes E.C., Wilson I.A., Donis R.O. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013, 9:e1003657.
74. Tusche C., Steinbruck L., McHardy A.C. Detecting patches of protein sites of influenza A viruses under positive selection. Mol. Biol. Evol. 2012, 29:2063-2071.
75. Underwood P.A., Skehel J.J., Wiley D.C. Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J. Virol. 1987, 61:206-208.
76. van Gils M.J., Bunnik E.M., Boeser-Nunnink B.D., Burger J.A., Terlouw-Klein M., Verwer N., Schuitemaker H. Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. J. Virol. 2011, 85:6986-6995.
77. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., Kuiken T. H5N1 virus attachment to lower respiratory tract. Science 2006, 312:399.
78. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., Kuiken T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 2007, 171:1215-1223.
79. Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 2007, 446:1023-1029.
80. Varki N.M., Varki A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab. Invest. 2007, 87:851-857.
81. Vigerust D.J., Ulett K.B., Boyd K.L., Madsen J., Hawgood S., McCullers J.A. N-linked glycosylation attenuates H3N2 influenza viruses. J. Virol. 2007, 81:8593-8600.
82. Walther T., Karamanska R., Chan R.W., Chan M.C., Jia N., Air G., Hopton C., Wong M.P., Dell A., Malik Peiris J.S., Haslam S.M., Nicholls J.M. Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLoS Pathog. 2013, 9:e1003223.
83. Wan H., Sorrell E.M., Song H., Hossain M.J., Ramirez-Nieto G., Monne I., Stevens J., Cattoli G., Capua I., Chen L.-M., Donis R.O., Busch J., Paulson J.C., Brockwell C., Webby R., Blanco J., Al-Natour M.Q., Perez D.R. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One 2008, 3:e2923.
84. Wang W., Lu B., Zhou H., Suguitan A.L., Cheng X., Subbarao K., Kemble G., Jin H. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J. Virol. 2010, 84:6570-6577.
85. Wanzeck K., Boyd K.L., McCullers J.A. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am. J. Respir. Crit. Care Med. 2011, 183:767-773.
86. Webster R.G., Laver W.G. Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology 1980, 104:139-148.
87. Weis W.I., Brunger A.T., Skehel J.J., Wiley D.C. Refinement of the influenza virus hemagglutinin by simulated annealing. J. Mol. Biol. 1990, 212:737-761.
88. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 1987, 56:365-394.
89. Wiley D.C., Wilson I.A., Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981, 289:373-378.
90. Winn M.D., Isupov M.N., Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr., D: Biol. Crystallogr. 2001, 57:122-133.
91. World Health Organization A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull. World Health Organ. 1980, 58:585-591.
92. Yang H., Carney P.J., Chang J.C., Villanueva J.M., Stevens J. Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus. J. Virol. 2013, 22:12433-12446.
93. Yang H., Carney P.J., Donis R.O., Stevens J. Structure and receptor complexes of the hemagglutinin from a highly pathogenic H7N7 influenza virus. J. Virol. 2012, 86:8645-8652.
94. Ye Y., Si Z.H., Moore J.P., Sodroski J. Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo. J. Virol. 2000, 74:11955-11962.